Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Revive Therapeutics Ltd
31RCurrent price
0.0005 EUR
0 EUR (0.00%)
Last closed
0.01 CAD
Company
www.revivethera.com
ISIN
CA7615161030
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
5 409 299 CAD
Yield for 12 month
-77.78 %
1Y
3Y
5Y
10Y
15Y
31R
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada. Address: The Canadian Venture Building, Toronto, ON, Canada, M5C 1P1
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures 31R
1 year
3 years
5 years
10 years
EBITDA
-3 431 487 CAD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.75 %
PEG Ratio
–
Return On Equity TTM
-39.01 %
Wall Street Target Price
–
Revenue TTM
–
Book Value
0.023 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.02 CAD
Diluted Eps TTM
-0.02 CAD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 31R
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 31R
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 31R
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.3919
Price Book MRQ
0.5477
Financials 31R
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 31R
For 52 weeks
0.005 CAD
0.06 CAD
50 Day MA
0.013 CAD
Shares Short Prior Month
11 047
200 Day MA
0.025 CAD
Short Ratio
0.16
Shares Short
119 085
Short Percent
0.08 %
BeatStart